Site Search

... consumers. This week the Administration released an amendment to its previous regulation on external appeals. The good news is that as a result of the regulation, virtually all people enrolled in private insurance, including ERISA self-insured plans, have the right to appeal, and the ... that were in existence before March 23, 2010 -– so called “grandfathered plans” -- and they remain largely unchanged in their benefits and cost-sharing.)                               Unfortunately, the regulation let consumers down, especially cancer patients who need to have disputes resolved quickly and fairly. Most notably, the scope of what can be appealed is limited to issues of "medical judgment.”   While medical judgment encompasses many possible disputes, the requirement fails ...

... Medicare and Medicaid eligibility and benefits. Because Medicare and Medicaid are critical programs for patients with chronic diseases, ACS CAN is partnering with the American Heart Association and the American Diabetes Association to include the patient voice in the debate. The attached fact sheets have been developed that can be used to help explain the importance of the Medicare and Medicaid programs to patients with chronic disease.  Medicaid~0117.pdf  Medicare Fact Sheet~Rev0113.pdf  FDA Committee Votes ... and Texas - states that have been wrestling with the decision of whether to accept federal dollars that have been set aside to finance the cost of providing health care coverage to up to 16 million hard working, low-income individuals nationwide. ACS CAN also briefed ACS CAN field ...

... Session ended on March 9 with 570 bills introduced. This was a significant increase from the 388 introduced in 2017 and 418 in 2016. The ACS CAN South Dakota team worked on many issues that will assist in the fight against cancer. Some key highlights of the 2018 Session are below: Increased access to Biosimilars The development of biologic drugs has provided patients and their physicians with ... small-molecule drugs, interchangeable biosimilars have the potential to increase price competition on older biologic drugs, and result in lower cost burdens for patients. Sen. Deb Soholt and Rep. Leslie Heinemann sponsored SB 75 that would create a new pathway for biologic substitution and ...

... Molly Medenblik LANSING, MI  – “As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize improving access to cancer care, increasing funding that will help prevent and detect cancer, and increasing funding to $5 million annually for tobacco prevention and cessation programs to ease the burden of cancer in Michigan.  “For roughly ten years, ACS CAN has advocated for the passage of oral chemotherapy fairness legislation and will continue to do so this year. This legislation would ensure that the out-of-pocket costs for oral ...